Enhanced prediction of thrombotic events in hospitalized COVID-19 patients with soluble thrombomodulin
PLOS ONE · 2025
DOI: 10.1371/journal.pone.0319666 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS ONE, 2025. Verfasst von Sergio Padilla und 10 weiteren Autor:innen. Beteiligte Einrichtung: Infectious Diseases Unit and Department of Clinical Medicine, Hospital General Universitario and Universidad Miguel Hernández de Elche, Alicante, Spa…. Hauptthemen laut MEDLINE: COVID-19, Thrombomodulin, Thrombosis. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Instituto de Salud Carlos III, FISABIO, Conselleria de Cultura, Educación y Ciencia, Generalitat Valenciana.
Abstract (Originalsprache)
We aimed to determine the predictive accuracy of elevated soluble thrombomodulin (sTM) and angiopoietin-2 (Ang2) for thrombotic events (TE) in hospitalized COVID-19 patients. We conducted a nested case-control study within a cohort of people admitted to hospital with COVID-19 from March 2020 to August 2022. The cases (people with TE within 28 days after hospital admission) were matched by propensity score to comparable patients without TE. We determined plasma levels of sTM and Ang2 in all available frozen samples, prioritizing the earliest post-admission samples, using an automated immunoassay technique. Among 2,524 hospitalized COVID-19 patients (43% females; median age 67 years), 73 had TE (incidence 1.15 events per 1000 patient-days of follow-up). Frozen plasma samples were available for 43 cases and 176 controls. Elevated plasma concentration of sTM was significantly associated with TE (2.8 [1.8, 4] vs. 1.52 [1.1, 2.65] ng/mL; p = 0.001) and mortality (median [Q1, Q3], 3.32 [2.16, 4.65] vs. 1.58 [1.11, 2.73] ng/mL; p = 0.001), while D-dimer showed a specific association with TE (2.3 [0.8, 7.4] vs. 0.75 [0.4, 1.6] mcg/mL; p = 0.001). In contrast, Ang2 was not associated with any of these events. The association with thrombotic events remained in adjusted models (HR [95%CI] per unit increase, 1.24 [1.04-1.47] for sTM; 1.07 [1.03-1.10] for D-dimer). The adjusted regression model that included both biomarkers, sTM and D-dimer, improved (AUC 73%, sensitivity 77% and specificity 65% for TE diagnosis; p = 0.007) the predictive capacity of the same model without sTM. In conclusion, determination of soluble thrombomodulin along with D-dimer enhances thrombotic risk assessment in hospitalized COVID-19 patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Infectious Diseases Unit and Department of Clinical Medicine, Hospital General Universitario and Universidad Miguel Hernández de Elche, Alicante, Spain.
- CIBER de Enfermedades Infecciosas (CIBERINFEC; Biomedical Research Networking Center for Infectious Diseases), Instituto de Salud Carlos III, Madrid, Spain.
- Internal Medicine Service and Department of Clinical Medicine, Hospital General Universitario and Universidad Miguel Hernández de Elche, Alicante, Spain.
- Hematology Department, Hospital General Universitario Dr. Balmis, Alicante, Spain.
- Infectious Diseases Unit, Hospital General Universitario de Elche, Alicante, Spain.
ORCID-Profile: Sergio Padilla
Förderung
- Instituto de Salud Carlos III
- FISABIO
- Conselleria de Cultura, Educación y Ciencia, Generalitat Valenciana
Zitieren
APA
Padilla, S., Andreo, M., Marco, P., Marco-Rico, A., Ledesma, C., Fernández-González, M., García-Abellán, J., Mascarell, P., Botella, Á., Gutiérrez, F., & Masiá, M. (2025). Enhanced prediction of thrombotic events in hospitalized COVID-19 patients with soluble thrombomodulin. PLOS ONE. https://doi.org/10.1371/journal.pone.0319666
Vancouver
Padilla S, Andreo M, Marco P, Marco-Rico A, Ledesma C, Fernández-González M, et al. Enhanced prediction of thrombotic events in hospitalized COVID-19 patients with soluble thrombomodulin. PLOS ONE. 2025. doi:10.1371/journal.pone.0319666
BibTeX
@article{Padilla2025,
author = {Padilla, Sergio and Andreo, María and Marco, Pascual and Marco-Rico, Ana and Ledesma, Christian and Fernández-González, Marta and García-Abellán, Javier and Mascarell, Paula and Botella, Ángela and Gutiérrez, Félix and Masiá, Mar},
title = {Enhanced prediction of thrombotic events in hospitalized COVID-19 patients with soluble thrombomodulin},
journal = {PLOS ONE},
year = {2025},
doi = {10.1371/journal.pone.0319666}
}
EUVIMED